X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (49264) 49264
Newsletter (9606) 9606
Publication (3554) 3554
Book Review (2219) 2219
Book Chapter (241) 241
Conference Proceeding (146) 146
Dissertation (55) 55
Newspaper Article (51) 51
Magazine Article (19) 19
Book / eBook (8) 8
Paper (5) 5
Data Set (2) 2
Government Document (2) 2
Reference (2) 2
Journal / eJournal (1) 1
Streaming Video (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (45409) 45409
animals (23802) 23802
humans (19743) 19743
oligopeptides - pharmacology (17273) 17273
oligopeptides (15795) 15795
oligopeptides - chemistry (12985) 12985
amino acid sequence (10777) 10777
male (10310) 10310
biochemistry & molecular biology (10062) 10062
oligopeptides - metabolism (9276) 9276
research (8645) 8645
mice (8083) 8083
rats (8039) 8039
molecular sequence data (7947) 7947
peptides (7142) 7142
female (6382) 6382
oligopeptides - chemical synthesis (5025) 5025
kinetics (4613) 4613
pharmacology & pharmacy (4420) 4420
proteins (4009) 4009
analysis (3926) 3926
structure-activity relationship (3315) 3315
reports (3238) 3238
protein conformation (3194) 3194
models, molecular (3188) 3188
cells, cultured (3164) 3164
oligopeptides - therapeutic use (3120) 3120
protein binding (2817) 2817
binding sites (2788) 2788
expression (2777) 2777
dose-response relationship, drug (2776) 2776
cell biology (2745) 2745
oligopeptides - administration & dosage (2742) 2742
cell line (2577) 2577
in vitro techniques (2509) 2509
chemistry, multidisciplinary (2390) 2390
substrate specificity (2331) 2331
cell line, tumor (2311) 2311
biophysics (2283) 2283
adult (2211) 2211
universities and colleges (2194) 2194
ligands (2145) 2145
time factors (2143) 2143
cells (2130) 2130
middle aged (2098) 2098
apoptosis (2039) 2039
physiological aspects (2039) 2039
oligopeptides - immunology (2032) 2032
abridged index medicus (2030) 2030
immunology (2014) 2014
oligopeptides - genetics (1995) 1995
binding (1983) 1983
rats, sprague-dawley (1979) 1979
peptide (1849) 1849
article (1844) 1844
protein (1820) 1820
molecular structure (1798) 1798
amino acids (1763) 1763
chemistry, medicinal (1759) 1759
neurosciences (1737) 1737
oncology (1716) 1716
identification (1691) 1691
peptides - chemistry (1680) 1680
cancer (1676) 1676
enzymes (1647) 1647
in-vitro (1609) 1609
activation (1581) 1581
chemistry, organic (1545) 1545
microbiology (1544) 1544
rats, wistar (1508) 1508
hydrogen-ion concentration (1496) 1496
receptor (1446) 1446
cattle (1423) 1423
protein structure, secondary (1409) 1409
apoptosis - drug effects (1403) 1403
magnetic resonance spectroscopy (1367) 1367
oligopeptides - pharmacokinetics (1356) 1356
endocrinology & metabolism (1355) 1355
phosphorylation (1335) 1335
chromatography, high pressure liquid (1330) 1330
gene expression (1327) 1327
base sequence (1324) 1324
mice, inbred c57bl (1322) 1322
biotechnology & applied microbiology (1311) 1311
rabbits (1307) 1307
thiols (1295) 1295
multidisciplinary sciences (1290) 1290
aged (1289) 1289
tumor cells, cultured (1287) 1287
hydrolysis (1284) 1284
biochemical research methods (1281) 1281
in-vivo (1258) 1258
cell adhesion (1256) 1256
chemistry (1248) 1248
medicine, research & experimental (1199) 1199
biochemistry (1198) 1198
oligopeptides - analysis (1197) 1197
signal transduction (1191) 1191
disease models, animal (1164) 1164
chemistry, analytical (1152) 1152
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (57169) 57169
Russian (869) 869
Chinese (289) 289
German (248) 248
Japanese (212) 212
French (122) 122
Spanish (70) 70
Italian (23) 23
Polish (18) 18
Czech (14) 14
Hungarian (14) 14
Ukrainian (12) 12
Portuguese (11) 11
Korean (10) 10
Danish (6) 6
Slovak (5) 5
Finnish (4) 4
Dutch (3) 3
Swedish (3) 3
Bulgarian (2) 2
Croatian (2) 2
Hebrew (2) 2
Greek (1) 1
Norwegian (1) 1
Romanian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Organic Chemistry, ISSN 1434-193X, 06/2016, Volume 2016, Issue 16, p. 2815
  We investigated the preferred conformations of l-Leu-Aib-alternating peptides, Boc-(l-Leu-Aib)n-OMe (n = 1: 1, 2: 2, 3: 3, 4: 4, 5: 5), in solution and in... 
Oligopeptides
Journal Article
Science, ISSN 0036-8075, 5/2010, Volume 328, Issue 5981, pp. 1031 - 1035
Poor penetration of anticancer drugs into tumors can be an important factor limiting their effícacy. We studied mouse tumor models to show that a previously... 
Molecules | Intravenous injections | Medical treatment | REPORTS | Antineoplastics | Antibodies | Liposomes | Dosage | Prostate cancer | Tumors | Cancer | NANOPARTICLES | INTEGRINS | MULTIDISCIPLINARY SCIENCES | MOUSE MODEL | IN-VIVO | DOXORUBICIN | PHAGE DISPLAY | VASCULAR-PERMEABILITY FACTOR | CELL | ENDOTHELIAL GROWTH-FACTOR | DELIVERY | Neoplasms - metabolism | Doxorubicin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Neuropilin-1 - metabolism | Albumin-Bound Paclitaxel | Humans | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Capillary Permeability - drug effects | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Paclitaxel - pharmacokinetics | Antineoplastic Agents - administration & dosage | Albumins - therapeutic use | Antibodies, Monoclonal, Humanized | Antineoplastic Agents - pharmacokinetics | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Oligopeptides - pharmacokinetics | Antibodies, Monoclonal - pharmacokinetics | Albumins - administration & dosage | Neoplasms - blood supply | Oligopeptides - metabolism | Permeability | Paclitaxel - therapeutic use | Doxorubicin - pharmacokinetics | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Albumins - pharmacokinetics | Animals | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice | Oligopeptides - administration & dosage | Oligopeptides - pharmacology | Trastuzumab | Antimitotic agents | Peptides | Research | Antineoplastic agents | Drug therapy | Health aspects | Chemotherapy | Index Medicus | Drugs | Nanoparticles | Side effects | Doxorubicin | Constraining
Journal Article
PLoS ONE, ISSN 1932-6203, 2009, Volume 4, Issue 12, pp. e8334 - e8334
Background: Kisspeptin and its G protein-coupled receptor (GPR) 54 are essential for activation of the hypothalamo-pituitary-gonadal axis. In the rat, the... 
MONKEY MACACA-MULATTA | GONADOTROPIN-RELEASING-HORMONE | RHESUS-MONKEY | BIOLOGY | PITUITARY-GONADAL AXIS | MEDIAN-EMINENCE | PULSATILE LH-RELEASE | ELECTRICAL-ACTIVITY | HYPOGONADOTROPIC HYPOGONADISM | OVARIECTOMIZED RATS | LUTEINIZING-HORMONE | Oligopeptides - antagonists & inhibitors | Preoptic Area - drug effects | Arcuate Nucleus of Hypothalamus - metabolism | Injections, Intraventricular | Rats | Luteinizing Hormone - metabolism | Oligopeptides - metabolism | Preoptic Area - metabolism | Rats, Sprague-Dawley | Kisspeptins | Animals | Signal Transduction - drug effects | Arcuate Nucleus of Hypothalamus - drug effects | Gonadotropin-Releasing Hormone - metabolism | Female | Oligopeptides - administration & dosage | Oligopeptides - pharmacology | Brain | Medical examination | Luteinizing hormone | Glycoproteins | Hormones, Sex | G proteins | Hormones | Blood | Membrane proteins | Neurosciences | Intravenous administration | Arcuate nucleus | Menopause | 17β-Estradiol | Hypothalamus | Nuclei | Cattle | Rodents | Pituitary-gonadal axis | Cannulae | Puberty | Medical research | Preoptic area | Ovariectomy | Secretion | Neurons | Pulse generators | Pituitary (anterior) | Gonadotropins | Monkeys & apes | Catheters | Sex hormones | Signaling | Brain research | Pituitary | Infertility | Gonadotropin-releasing hormone | Kiss1 protein | Endocrinology | Index Medicus
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2010, Volume 54, Issue 6, pp. 1114 - 1122
Background & Aims BI201335 is a highly specific and potent HCV protease inhibitor. This multiple rising dose trial evaluated antiviral activity and safety in... 
Gastroenterology and Hepatology | Antiviral | Resistant variants | Hepatitis C virus | Pegylated interferon | Ribavirin | PLUS RIBAVIRIN | BILN-2061 | TELAPREVIR | EFFICACY | VX-950 | HEPATITIS-C-VIRUS | IN-VITRO | EARLY ANTIVIRAL ACTIVITY | PEGINTERFERON ALPHA-2A | ATAZANAVIR | GASTROENTEROLOGY & HEPATOLOGY | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Protease Inhibitors - pharmacokinetics | Humans | Middle Aged | Hepacivirus - genetics | Male | Thiazoles - administration & dosage | Recombinant Proteins | Oligopeptides - adverse effects | Thiazoles - adverse effects | Thiazoles - pharmacokinetics | Protease Inhibitors - pharmacology | Hepatitis C - blood | Ribavirin - administration & dosage | Protease Inhibitors - administration & dosage | Protease Inhibitors - adverse effects | Adult | Female | Hepacivirus - drug effects | Antiviral Agents - pharmacology | Double-Blind Method | Oligopeptides - pharmacokinetics | Carrier Proteins - antagonists & inhibitors | Viral Nonstructural Proteins - genetics | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Interferon-alpha - administration & dosage | Drug Resistance, Viral - genetics | Hepacivirus - enzymology | Antiviral Agents - adverse effects | Hepatitis C - virology | Oligopeptides - administration & dosage | Thiazoles - pharmacology | Oligopeptides - pharmacology | Viral Load - drug effects | Viral Nonstructural Proteins - antagonists & inhibitors | Medical colleges | Antiviral agents | Care and treatment | Safety and security measures | Hotels and motels | Immunodeficiency | Aspartate | Biological response modifiers | HIV (Viruses) | Anti-HIV agents | Complications and side effects | Protease inhibitors | Proteases | Genetic aspects | Hepatitis C | Index Medicus | Viral Nonstructural Proteins | Oligopeptides | Polyethylene Glycols | Interferon-alpha | Protease Inhibitors | Drug Resistance, Viral | Antiviral Agents | Viral Load | Life Sciences | Thiazoles | Hepacivirus | Carrier Proteins | Cancer
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 08/2014, Volume 55, Issue 8, pp. 1248 - 1252
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 12/2014, Volume 136, Issue 48, pp. 16940 - 16946
Although the syntheses of novel and diverse peptides rely mainly on traditional coupling using unnatural amino acids, postsynthetic modification of peptides... 
Amino Acids - chemistry | Oligopeptides - chemical synthesis | Ligands | Oligopeptides - chemistry | Molecular Conformation | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2012, Volume 48, Issue 18, pp. 3319 - 3327
Abstract Background SF1126 is a peptidic pro-drug inhibitor of pan-PI3K/mTORC. A first-in-human study evaluated safety, dose limiting toxicities (DLT), maximum... 
Hematology, Oncology and Palliative Medicine | Pharmacodynamics | PI3K/mTORC pathway | SF1126 | Pharmacokinetics | Refractory solid tumours | B-cell malignancies | ACTIVATION | ANGIOGENESIS | PHOSPHATIDYLINOSITOL 3-KINASE | KINASE | GUIDELINES | CANCER | ONCOLOGY | PI3K PATHWAY | CHRONIC LYMPHOCYTIC-LEUKEMIA | INHIBITOR | ASSOCIATION | Humans | Middle Aged | Male | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Oligopeptides - therapeutic use | Young Adult | Chromones - adverse effects | Aged, 80 and over | Antineoplastic Agents - pharmacokinetics | Chromones - pharmacology | Protein Kinase Inhibitors - pharmacokinetics | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - enzymology | Neoplasms - drug therapy | Protein Kinase Inhibitors - administration & dosage | Leukemia, Lymphocytic, Chronic, B-Cell - enzymology | Maximum Tolerated Dose | Oligopeptides - administration & dosage | TOR Serine-Threonine Kinases | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Oligopeptides - pharmacology | Proteins - antagonists & inhibitors | Prodrugs - administration & dosage | Multiprotein Complexes | Salvage Therapy | Chromones - administration & dosage | Molecular Targeted Therapy | Oligopeptides - adverse effects | Mechanistic Target of Rapamycin Complex 1 | Dose-Response Relationship, Drug | Antineoplastic Agents - adverse effects | Hypokalemia - chemically induced | Adult | Female | Antineoplastic Agents - pharmacology | Chromones - therapeutic use | Hematologic Diseases - chemically induced | Oligopeptides - pharmacokinetics | Neoplasms - enzymology | Chromones - pharmacokinetics | Prodrugs - adverse effects | Prodrugs - pharmacokinetics | Protein Kinase Inhibitors - therapeutic use | Aged | Prodrugs - therapeutic use | Protein Kinase Inhibitors - pharmacology | Infusions, Intravenous | Prodrugs - pharmacology | Gastrointestinal Diseases - chemically induced | Medicine, Experimental | Medical research | Care and treatment | Emergency medical services | Cancer | Index Medicus | PI3K | mTORC pathway
Journal Article
Amino Acids, ISSN 0939-4451, 02/2015, Volume 47, Issue 2, p. 291
Secondary structure formation in oligopeptides can be induced by short nucleating segments with a high propensity to form hydrogen bonded turn conformations.... 
Oligopeptides | Hydrogen
Journal Article
Molecular Neurobiology, ISSN 0893-7648, 07/2019, Volume 56, Issue 7, p. 4980
Alzheimer's disease (AD) results from over-production and aggregation of [beta]-amyloid (A[beta]) oligopeptides in the brain. The benefits of regular physical... 
Brain | Oligopeptides | Analysis
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 01/2008, Volume 68, Issue 1, pp. 206 - 215
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 05/2009, Volume 52, Issue 9, pp. 3028 - 3038
Journal Article
Journal Article
1983, Peptides, ISBN 9783136396018, Volume 5., 341
Book
Bioconjugate Chemistry, ISSN 1043-1802, 04/2015, Volume 26, Issue 4, pp. 650 - 659
Journal Article
Nature Biotechnology, ISSN 1087-0156, 07/2003, Volume 21, Issue 7, pp. 778 - 784
Journal Article